← BioTransfer GEO Dataset Finder
GEO series

Dissecting cellular state alterations critical for the synergistic response and therapy resistance of the combined Abemaciclib, Temozolomide, and Radiation in DIPG PDOX models

GSE301111 Homo sapiens; Mus musculus Expression profiling by high throughput sequencing 14 samples Submitted 2026/08/07 Platform GPL34284Platform GPL34290
Summary
Diffuse intrinsic pontine glioma (DIPG) is a lethal pediatric brain cancer. Here, we demonstrated that combining the CDK4/6 inhibitor abemaciclib with temozolomide and radiation (the triple therapy) yields synergistic anti-tumor effects in DIPG organoids and significantly extends survival times in patient-derived orthotopic (intra-brain stem) xenograft (PDOX) models. Mechanistically, we performed scRNA-seq and identified dynamic reprogramming of tumor cell states, including the expansion of NPC-like, depletion of OPC- and AC-like subpopulations, and persistence of MES-like and mitotic-like cells, that contributed to therapeutic resistance. Pseudotime trajectory analysis further revealed therapy-induced cell fate transitions within NPC- and OPC-like compartments, including the enrichment of stem-like cells. More importantly, we discovered that an alternative trajectory—exit from stemness toward more differentiated states—may also contribute to therapeutic failure. Additionally, we identified a novel radiation-resistant subpopulation and found a new set of transcriptional targets indicative of therapeutic vulnerability. This study demonstrated the triple therapy as a promising DIPG regimen that can be rapidly translated into clinical trials and nominated new cellular and molecular targets to overcome residual disease.
Published in
Therapy-associated lineage plasticity in DIPG following combined CDK4/6 inhibitor, temozolomide, and radiation
Huang ZL, Jiang T, Suarez Palacios MM et al. · Cancer letters 2026 · PMID 42532370 · doi:10.1016/j.canlet.2026.218771
This dataset
Download

Direct links to NCBI, no account and no request form: the whole study as GSE301111_RAW.tar, processed values as the series matrix, the supplementary file directory, and per-sample supplementary files for any of the 14 samples. Raw sequencing reads are also available from ENA.

Also filed as BioProject PRJNA1283950 and SRA study SRP597919. Searching any of these in the dataset finder brings you back here.

Study design
13 conditions, each sampled once — no replicated groups
IBs-A0317DIPG PDOX model treated with temozol… ×2

Supports a case/control comparison: 11 samples read as cases, 2 as controls.

Read from 14 sample titles: 13 distinct titles with little repetition. Check it against the sample list below before relying on it.

Samples in this study
Similar datasets

Search all RNA-seq datasets in GEO →

Share this dataset

Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.